Institutional Ownership
Galecto Inc
CUSIP 36322Q206COM NEWDMRAQ1 2026
13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
62
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
9 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G | 6.0% | 3.60M | SEC |
| 2 | Feb 17, 2026 | Jain Global LLC | 13G | 7.5% | 120.6K | SEC |
| 3 | Feb 11, 2026 | Fairmount Funds Management LLC | 13D/A | 20.0% | — | SEC |
| 4 | Jan 12, 2026 | Paramora Holding LLC | 13G | 11.0% | 120.5K | SEC |
| 5 | Jan 12, 2026 | Paragon Therapeutics, Inc. | 13G | 11.0% | 120.5K | SEC |
| 6 | Dec 5, 2025 | Fmr LLC | 13G | 15.0% | 238.9K | SEC |
| 7 | Nov 17, 2025 | Fairmount Funds Management LLC | 13D | 20.0% | — | SEC |
| 8 | Nov 13, 2025 | Point72 Asset Management, L.P. | 13G | 6.3% | 100.0K | SEC |
| 9 | Nov 7, 2024 | Sunstone Life Science Ventures A/S | 13G/A | 2.4% | 29.5K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 9.05M | $234.28M |
| 2 | Fairmount Funds Management LLC | 8.71M | $225.67M |
| 3 | Avoro Capital Advisors LLC | 3.78M | $97.98M |
| 4 | Venrock Adviser, LLC | 3.60M | $93.33M |
| 5 | Fcpm III Services B.V. | 2.44M | $63.22M |
| 6 | Ra Capital Management, L.P. | 2.40M | $62.14M |
| 7 | Janus Henderson Group PLC | 2.36M | $61.44M |
| 8 | Viking Global Investors LP | 2.31M | $59.86M |
| 9 | Bellevue Group AG | 2.30M | $59.52M |
| 10 | Remedium Capital Partners, LLC | 2.05M | $52.98M |